Canvas Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Canvas Wealth Advisors's BMY Position: Q2 2026 in Review
Canvas Wealth Advisors increased its Bristol-Myers Squibb (BMY) stake by 19% in Q2 2026, buying an estimated $41.6K and bringing the position to 4,554 shares worth $262K. The position accounts for 0.04% of the portfolio, ranked #213.
Canvas Wealth Advisors first reported a position in BMY in Q1 2026 and has held it in 2 quarters since. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Canvas Wealth Advisors held 4,554 shares of Bristol-Myers Squibb worth $262K as of Q2 2026.
- Canvas Wealth Advisors bought 724 Bristol-Myers Squibb shares in Q2 2026, an estimated $41.6K.
- Bristol-Myers Squibb made up 0.04% of Canvas Wealth Advisors's portfolio in Q2 2026, its #213 holding.
- Canvas Wealth Advisors first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 2 quarters since.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Canvas Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.